Oncologic, fertility, and obstetric outcomes with MPA therapy in women with endometrial cancer and atypical endometrial hyperplasia.
Asuka TakedaYuri YamamotoKou TamuraHidenori AokiHiroki NoguchiSaki MinatoShuhei KamadaRyosuke ArakakiTakashi KajiTakeshi IwasaPublished in: The journal of obstetrics and gynaecology research (2023)
MPA therapy can produce a high remission rate, and be considered an effective treatment for patients who wish fertility preservation. Around 70% patients who attempt to pregnancy can have at least one baby by infertility treatments. Because recurrence rate after MPA therapy is high, it may be desirable to aim for early pregnancy by active intervention.
Keyphrases
- endometrial cancer
- randomized controlled trial
- pregnant women
- prostate cancer
- type diabetes
- rheumatoid arthritis
- preterm birth
- adipose tissue
- metabolic syndrome
- young adults
- mesenchymal stem cells
- insulin resistance
- bone marrow
- robot assisted
- combination therapy
- minimally invasive
- replacement therapy
- weight loss
- ulcerative colitis